What is Azenta's market cap?

Azenta (AZTA) has a market capitalization of $1.3B and trades on NASDAQ.

What is Azenta's revenue and profitability?

Azenta generated $596.5M in trailing twelve-month revenue with a net loss of $173.3M, representing a net margin of -29.1%. Gross margin stands at 40.0%, with free cash flow of $42.7M. These figures are based on the Q1 2026 filing.

Who are Azenta's competitors?

Azenta's key competitors include Thermo Fisher Scientific Inc., Illumina, Inc., Twist Bioscience Corporation, and others. These companies compete in similar markets and product categories.

What subsidiaries does Azenta have?

Azenta's subsidiaries include B Medical Systems.

Where is Azenta headquartered?

Azenta is headquartered in United States of America and employs approximately 3,400 people. It has been publicly traded since 1995.

Azenta

AZTA

Azenta is a leading global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry.

Market cap

$1.27B-17.1%

Revenue$596.5M-5.9%

Net income-$173.3M-141%

Free cash flow$42.7M+33.2%

EPS (diluted)-$7.28-2,933%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q2 2026 report

May 6, 2026

Revenue$144.8MMiss by $3.5M EPS-$0.04Miss by $0.14

Read the full report

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$149.2M

EPS estimate$0.11

Financials

Q2 2026

Income statement

See full

Revenue$144.8M+1.0%

Gross profit$62.0M-1.2%

Operating income-$165.8M-811%

Net income-$160.8M-237%

EPS (diluted)-$3.49-236%

Balance sheet

See full

Cash & equivalents$125.2M—

Total debt$55.7M—

Total equity$1.6B-8.3%

Total assets$1.9B—

Cash flow

See full

Operating cash flow$13.5M-6.2%

CapEx$7.4M-0.1%

Free cash flow$6.1M-12.7%

Valuation & ratios

Valuation

See full

Market cap$1.27B-17.1%

Enterprise value$1.2B—

P/S2.1×-0.5×

Profitability

See full

Net margin-29.1%-80.7pp

Returns & leverage

See full

Return on equity-10.7%-22.4pp

Debt / equity0×—

Current ratio2.8×—

Segments

By geography

See full

Rest of Europe$25.9M+2.4%

Asia Pacific (Excluding China)$7.5M+18.2%

Other$1.1M+6.3%

By segment

See full

Multiomics$63.7M+0.3%

By product

See full

Services$107.2M+5.6%

Competitors

By market cap

Thermo Fisher Scientific$207.93B+13.6%

Danaher$138.14B-4.9%

Illumina$28.7B+64.8%

Labcorp Holdings$24.7B+13.8%

Twist Bioscience Corporation$5.4B+146%

BioLife Solutions$1.5B+36.9%

Azenta$1.3B-18.8%

iSpecimen$2.9M+5.2%

By revenue growth

BioLife Solutions+27.5%

Twist Bioscience Corporation+17.8%

Labcorp Holdings+7.3%

Thermo Fisher Scientific+5.6%

Danaher+4.6%

Illumina+1.3%

Azenta-5.9%

By net margin

Illumina19.42%+41.7pp

Danaher15.95%+1.7pp

Thermo Fisher Scientific15.19%0.0pp

Labcorp Holdings6.66%+1.1pp

Twist Bioscience Corporation-19.85%+35.1pp

Azenta-29.06%-17.7pp

BioLife Solutions-68.71%+46.3pp

Profile

Azenta is a leading global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The company provides a comprehensive suite of automated storage systems, genomic services, and informatics to support customers from research and clinical development through commercialization. Its core value proposition centers on ensuring sample integrity and accelerating the delivery of impactful therapies to market.

Competitive position

A leading global provider with a unique integrated portfolio combining automated cold storage hardware with advanced multiomics laboratory services.

GeographiesNorth America, Europe, Asia, Middle East

Customer segmentsPharmaceutical Companies, Biotechnology Companies, Academic Institutions, Government Research Agencies, Clinical Research Organizations

Business modelB2B Service, Manufacturing, Professional Services, SaaS

SuppliersRaw material suppliers, Electronic component manufacturers, Specialized laboratory equipment providers, Logistics and courier partners

CustomersDrug discovery teams, Clinical trial managers, Biobank managers, Genomic researchers, Therapy commercialization partners

CountryUnited States of America

Listed1995

Employees3.4K

CEOJohn Marotta

SectorHealthcare

IndustryMedical - Instruments & Supplies

Websiteazenta.com

FilingsSEC EDGAR

Ask your AI about Azenta.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Azenta's market cap?: Azenta (AZTA) has a market capitalization of $1.3B and trades on NASDAQ.
What is Azenta's revenue and profitability?: Azenta generated $596.5M in trailing twelve-month revenue with a net loss of $173.3M, representing a net margin of -29.1%. Gross margin stands at 40.0%, with free cash flow of $42.7M. These figures are based on the Q1 2026 filing.
Who are Azenta's competitors?: Azenta's key competitors include Thermo Fisher Scientific Inc., Illumina, Inc., Twist Bioscience Corporation, and others. These companies compete in similar markets and product categories.
What subsidiaries does Azenta have?: Azenta's subsidiaries include B Medical Systems.
Where is Azenta headquartered?: Azenta is headquartered in United States of America and employs approximately 3,400 people. It has been publicly traded since 1995.